Analysis

The Chinese electric-vehicle maker XPeng has kicked off sales of its flagship X9 van across Europe, but the premium model's...

The initial frenzy around SpaceX's public listing has cooled sharply. After two straight days of losses, the stock slid more...

BayWa’s first-quarter revenue collapsed 34% to €2.3 billion, deepening the crisis for the embattled German agribusiness group as it juggles...

Two powerful catalysts are converging at D-Wave Quantum. The company is rolling out a novel error-revealing simulator in September, while...

Two legal milestones are converging on Bayer within weeks, and the market is holding its breath. By the end of...

That warning comes from a series of recent rulings spanning wage claims, internal investigations, overtime disputes, and email delivery —...

The clock is ticking in two directions for XPeng. The electric-vehicle maker’s stock is hovering just a hair above its...

The countdown has begun for Outlook Therapeutics, with the U.S. Food and Drug Administration setting a binding decision date of...

The payments processor Fiserv is facing a pivotal moment, with a change at the top coming at the same time...

The euphoria that propelled SpaceX's stock 67% higher in its first three days of trading has given way to a...